InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change in substantial holding from SOL 12 May 2017 12:23AM $2.190 $1.530 fallen by 30.14%
- API HY17 Results Presentation 20 Apr 2017 8:53AM $2.040 $1.530 fallen by 25%
- API HY17 Results ASX Release 20 Apr 2017 8:53AM $2.040 $1.530 fallen by 25%
- Dividend/Distribution - API 20 Apr 2017 8:50AM $2.040 $1.530 fallen by 25%
- Half Yearly Report and Accounts 20 Apr 2017 8:48AM $2.040 $1.530 fallen by 25%
- API HY17 Financial Results 13 Apr 2017 10:59AM $2.090 $1.530 fallen by 26.79%
- Appendix 3B 16 Mar 2017 2:29PM $2.035 $1.530 fallen by 24.82%
- Change of Director's Interest Notice 16 Mar 2017 2:26PM $2.035 $1.530 fallen by 24.82%
- Ceasing to be a substantial holder from CBA 17 Feb 2017 4:36PM $1.870 $1.530 fallen by 18.18%
- Alternate Company Secretary Appointment 15 Feb 2017 9:30AM $1.920 $1.530 fallen by 20.31%
- Initial Director's Interest Notice 15 Feb 2017 9:28AM $1.920 $1.530 fallen by 20.31%
- Final Director's Interest Notice 15 Feb 2017 9:27AM $1.920 $1.530 fallen by 20.31%
- Appendix 3B 3 Feb 2017 9:10AM $1.870 $1.530 fallen by 18.18%
- API - CEO terms of employment 25 Jan 2017 4:15PM $1.965 $1.530 fallen by 22.14%
- Final Director's Interest Notice - Carol Holley 25 Jan 2017 4:14PM $1.965 $1.530 fallen by 22.14%
- 2016 AGM - Results of Meeting 25 Jan 2017 4:11PM $1.965 $1.530 fallen by 22.14%
- 2016 AGM - CEO-Elect Address to Shareholders 25 Jan 2017 2:01PM $1.995 $1.530 fallen by 23.31%
- 2016 AGM - CEO and MD Address to Shareholders 25 Jan 2017 1:56PM $2.020 $1.530 fallen by 24.26%
- 2016 AGM -Chairman's Address to Shareholders 25 Jan 2017 1:55PM $2.020 $1.530 fallen by 24.26%
- 2016 AGM - Presentation to Shareholders 25 Jan 2017 1:47PM $2.020 $1.530 fallen by 24.26%
- API - 2016 AGM arrangements 18 Jan 2017 11:25AM $2.010 $1.530 fallen by 23.88%
- Proxy Form - 2016 Annual General Meeting 9 Dec 2016 10:19AM $1.890 $1.530 fallen by 19.05%
- Annual Report to Shareholders - 2016 9 Dec 2016 9:24AM $1.885 $1.530 fallen by 18.83%
- Corporate Governance Statement 9 Dec 2016 9:23AM $1.885 $1.530 fallen by 18.83%
- Key to Disclosures - Appendix 4G 9 Dec 2016 9:22AM $1.885 $1.530 fallen by 18.83%

301 - 325 of 477 results

Page 13 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.